Dog Epithelia

This article discusses clinical trials investigating the use of Dog Epithelia in allergy treatments. Dog Epithelia, a common allergen, is being studied as a potential component in immunotherapy for allergic conditions such as rhinitis and rhinoconjunctivitis. These trials aim to assess the efficacy and safety of various formulations containing Dog Epithelia for managing allergic symptoms and improving patients’ quality of life.

Table of Contents

What is Dog Epithelia?

Dog epithelia is a substance derived from the skin and hair of dogs. It is classified as a structurally diverse substance – allergen, which means it contains proteins that can trigger allergic reactions in some people[1]. Dog epithelia is used in medical settings, particularly in allergy testing and treatment.

Medical Uses

The primary medical use of dog epithelia is in the diagnosis and treatment of dog allergies. It is used in two main ways:

  1. Allergy Testing: Dog epithelia is used in skin prick tests to diagnose dog allergies. A small amount of the allergen is placed on the skin, and if a person is allergic, a small bump or wheal will appear[1].
  2. Immunotherapy: For people with confirmed dog allergies, dog epithelia may be used in allergen immunotherapy. This treatment involves exposing the patient to small, controlled amounts of the allergen over time to reduce sensitivity and allergic reactions[1].

Administration

Dog epithelia is typically administered in two ways:

  • Cutaneous Use: This refers to application on the skin, typically for allergy testing. The solution is applied as a drop on the skin[1].
  • Subcutaneous Use: This method involves injecting the allergen under the skin, usually as part of immunotherapy treatment[2].

The dosage can vary depending on the specific use and individual patient needs. For skin prick tests, a single drop (about 0.02 ml) is typically used. For immunotherapy, the dosage and schedule would be determined by an allergist based on the patient’s specific condition and response to treatment[1][2].

Clinical Trials

While the clinical trials mentioned in the provided data do not directly involve dog epithelia, they offer insights into how allergen immunotherapy is studied and administered. These trials focus on other common allergens like house dust mites and birch pollen, but the principles are similar for dog allergy treatments[1][2].

Key points from these trials that may be relevant to dog epithelia treatments include:

  • Immunotherapy treatments are typically given over an extended period, often a year or more.
  • The effectiveness of the treatment is usually measured by comparing symptoms and medication use between treated patients and those receiving a placebo.
  • Researchers often look at changes in specific antibody levels (like IgE, IgG, and IgG4) to assess the immune system’s response to the treatment.
  • Quality of life improvements are an important outcome measure in allergy treatments.

Potential Side Effects

While specific side effects of dog epithelia treatments are not detailed in the provided information, allergen immunotherapy in general can have some side effects, including:

  • Local reactions at the injection site (for subcutaneous immunotherapy), such as redness, swelling, or itching
  • In rare cases, more severe allergic reactions

It’s important to note that these treatments are always administered under medical supervision, and patients are typically observed for a period after each dose to monitor for any adverse reactions[1][2].

Precautions

Based on the information from similar allergy treatments, several precautions should be considered for dog epithelia treatments:

  • Patients with uncontrolled asthma, severe immune disorders, or certain other health conditions may not be suitable candidates for this treatment.
  • Pregnancy and breastfeeding may affect eligibility for treatment.
  • Certain medications, particularly those that affect the immune system, may interfere with the treatment.
  • Patients should inform their doctor about all medications they are taking and any changes in their health status during the course of treatment.

Always consult with a healthcare professional or allergist for personalized advice and treatment options for dog allergies[1][2].

Aspect Details
Study Focus Clinical trials investigating Dog Epithelia in allergy treatments
Target Conditions Moderate to severe allergic rhinitis and rhinoconjunctivitis
Administration Methods Skin prick test solutions, subcutaneous immunotherapy
Primary Objectives Assess efficacy, safety, and tolerability of treatments
Key Measurements Symptom scores, medication use, quality of life improvements
Participant Criteria Age 12-65, history of allergic conditions, positive allergy tests
Safety Considerations Exclusion of severe asthma, certain medical conditions, and medications

Ongoing Clinical Trials on Dog Epithelia

  • Study on the Effectiveness of PURETHAL Mites for Adults with Moderate to Severe Allergic Rhinitis or Rhinoconjunctivitis Due to House Dust Mite Allergy

    Not recruiting

    3 1 1
    Austria Bulgaria Germany Latvia Lithuania Poland
  • Study on the Effects of Mannan-Conjugated Birch Pollen Allergoids for Adolescents and Adults with Birch Pollen-Induced Allergic Rhinitis or Rhinoconjunctivitis

    Not recruiting

    3 1 1
    Investigated diseases:
    Germany

Glossary

  • Allergen: A substance that can cause an allergic reaction in some people. In these trials, dog epithelia is an example of an allergen.
  • Allergic Rhinitis: An allergic condition affecting the nose, causing symptoms such as sneezing, runny nose, and nasal congestion in response to allergens.
  • Rhinoconjunctivitis: An allergic condition affecting both the nose and eyes, causing symptoms in both areas when exposed to allergens.
  • Immunotherapy: A treatment approach that aims to modify the immune system's response to allergens, potentially reducing allergic symptoms over time.
  • Subcutaneous: Underneath the skin. In these trials, some treatments are administered via subcutaneous injection.
  • Skin Prick Test: A diagnostic test where small amounts of allergens are placed on the skin to check for allergic reactions.
  • Placebo: An inactive substance used in clinical trials to compare the effects of the real treatment against no treatment.
  • FEV1: Forced Expiratory Volume in 1 second, a measure of lung function often used to assess asthma severity.
  • IgE: Immunoglobulin E, an antibody produced by the immune system in response to allergens.
  • ARIA: Allergic Rhinitis and its Impact on Asthma, a guideline used to classify the severity of allergic rhinitis.

References

  1. http://clinicaltrials.eu/trial/study-on-the-effectiveness-of-purethal-mites-for-adults-with-moderate-to-severe-allergic-rhinitis-or-rhinoconjunctivitis-due-to-house-dust-mite-allergy/
  2. http://clinicaltrials.eu/trial/study-on-the-effects-of-mannan-conjugated-birch-pollen-allergoids-for-adolescents-and-adults-with-birch-pollen-induced-allergic-rhinitis-or-rhinoconjunctivitis/